| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -204K | 100% | $41.43 | -$8.43M |
| Net | -2 | -204K | -100% | -$8.43M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yujiro S. Hata | President and CEO, Director | $13.5M | -$7.4M | -35.4% | Feb 27, 2025 |
| Michael P. Dillon | SVP, Chief Scientific Officer | $3.31M | Oct 4, 2021 | ||
| Jason Throne | Chief Legal Officer | $445K | Jun 27, 2024 | ||
| Paul A. Stone | Chief Financial Officer | $391K | Aug 29, 2023 | ||
| Michael Anthony White | Chief Scientific Officer | $0 | -$1.03M | -100% | Feb 27, 2025 |
| Terry J. Rosen | Director | May 31, 2024 | |||
| Catherine J. Mackey | Director | May 31, 2024 | |||
| Darrin Beaupre | Chief Medical Officer | Feb 27, 2025 | |||
| Scott W. Morrison | Director | May 31, 2024 | |||
| Malcolm Garret Hampton | Director | May 31, 2024 | |||
| Timothy M. Shannon | Director | Jun 7, 2023 | |||
| Stuart Dorman | Chief Commercial Officer | Feb 27, 2025 | |||
| Susan L. Kelley | Director | May 31, 2024 | |||
| Douglas B. Snyder | SVP, General Counsel | Feb 27, 2025 | |||
| Andres Ruiz | Title: SVP, Head of Finance and Investor Relations | Feb 27, 2025 | |||
| Wendy L. Yarno | Director | May 31, 2024 | |||
| Jeffrey Stein | Director | May 31, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|